These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11244641)

  • 1. [Controversy: systemic amniocentesis for women 38 years and more? Is it still lawful to recommend amniocentesis with the sole criterion being maternal age of 38 years or more?].
    Bernard JP
    Gynecol Obstet Fertil; 2000 Oct; 28(10):765-9. PubMed ID: 11244641
    [No Abstract]   [Full Text] [Related]  

  • 2. [Controversy: systemic amniocentesis for women 38 years and more? Is it not premature to no longer accept performing amniocentesis on a patient age 38 years or more?].
    Sagot P
    Gynecol Obstet Fertil; 2000 Oct; 28(10):769-71. PubMed ID: 11270348
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prenatal cytogenetic diagnosis in the 2d trimester in older pregnant women].
    Subrt I; Benesová O; Stirská K; Zwinger A
    Cesk Gynekol; 1989 Nov; 54(9):677-80. PubMed ID: 2533885
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rescheduling genetic amniocentesis from the 16th to the 13th/14th week of pregnancy--report of experience].
    Huter O; Brezinka C; Fessler S; Kraft HG; Duba HC
    Geburtshilfe Frauenheilkd; 1993 Nov; 53(11):788-91. PubMed ID: 8293946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening for Down's syndrome at week 10-14 by measuring fetal nuchal translucency thickness].
    Maymon R; Dreazen E; Weinraub Z; Bukovsky I; Herman A
    Harefuah; 1999 Nov; 137(9):353-7, 432. PubMed ID: 11419032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of amniocentesis in women screened positive for Down syndrome with second trimester maternal serum markers.
    Muller F; Thibaud D; Poloce F; Gelineau MC; Bernard M; Brochet C; Millet C; Réal JY; Dommergues M
    Prenat Diagn; 2002 Nov; 22(11):1036-9. PubMed ID: 12424771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counseling for low maternal serum alpha-fetoprotein should emphasize all chromosome anomalies, not just Down syndrome.
    Drugan A; Dvorin E; Koppitch FC; Greb A; Krivchenia EL; Evans MI
    Obstet Gynecol; 1989 Feb; 73(2):271-4. PubMed ID: 2463504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
    Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA
    N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Down syndrome.
    Lancet; 1987 Nov; 2(8567):1083-4. PubMed ID: 2444843
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of amniocentesis.
    Lancet; 1986 Jul; 2(8500):225-6. PubMed ID: 2873473
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of persistent amniotic fluid leakage after genetic amniocentesis.
    Crane JP; Rohland BM
    Prenat Diagn; 1986; 6(1):25-31. PubMed ID: 3952058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prenatal diagnosis of fetal malformations from the obstetrician's viewpoint].
    Winter R
    Wien Klin Wochenschr; 1983 Feb; 95(3):67-78. PubMed ID: 6190319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal diagnosis of cytogenetic abnormalities.
    Simpson JL
    Semin Perinatol; 1980 Jul; 4(3):165-78. PubMed ID: 6447915
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of chromosome aberrations in the second trimester using genetic amniocentesis: experience during 1995-2004.
    Tseng JJ; Chou MM; Lo FC; Lai HY; Chen MH; Ho ES
    Taiwan J Obstet Gynecol; 2006 Mar; 45(1):39-41. PubMed ID: 17272206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic findings in over 2000 amniocenteses.
    Allanson JE; McGillivray BC; Hall JG; Shaw D; Kalousek DK
    Can Med Assoc J; 1983 Oct; 129(8):846-50. PubMed ID: 6225506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost analysis of Down syndrome screening in advanced maternal age.
    Hartnett J; Borgida AF; Benn PA; Feldman DM; DeRoche ME; Egan JF
    J Matern Fetal Neonatal Med; 2003 Feb; 13(2):80-4. PubMed ID: 12735407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of routine fetal nuchal translucency measurement at weeks 10-13 in 4233 unselected pregnant women.
    Hafner E; Schuchter K; Liebhart E; Philipp K
    Prenat Diagn; 1998 Jan; 18(1):29-34. PubMed ID: 9483637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five hundred cases of amniocentesis without bloody tap.
    Katayama KP; Roesler MR
    Obstet Gynecol; 1986 Jul; 68(1):70-3. PubMed ID: 3523332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific incidences of chromosome abnormalities at the second trimester amniocentesis for Japanese mothers aged 35 and older: collaborative study of 5484 cases.
    Yaegashi N; Senoo M; Uehara S; Suzuki H; Maeda T; Fujimori K; Hirahara F; Yajima A
    J Hum Genet; 1998; 43(2):85-90. PubMed ID: 9621511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.